Pfizer agrees to license generic versions of its COVID-19 pill — in some countries
(By Bill Chappell for NPR) Pfizer has signed a licensing deal to allow dozens of lower-income countries to benefit from
Read More(By Bill Chappell for NPR) Pfizer has signed a licensing deal to allow dozens of lower-income countries to benefit from
Read More(By Sarah Jane Tribble and Emily Featherston, Investigate TV for Kaiser Health News) In early July, as the covid-19 pandemic
Read More(By Nick Moran for Becker’s Hospital Review) CMS announced Nov. 13 that Medicare Part B premiums and deductibles will see the
Read More(By STAT staff) The past two months have brought extremely good news in the fight against Covid-19. Two different oral
Read More(By Nick Moran for Becker’s Hospital Review) Eighty-two percent of Americans prepared to enroll in a health plan ahead of 2021’s
Read More(By Susan Jaffe for Kaiser Health News) Finding the best private Medicare drug or medical insurance plan among dozens of
Read More(By Harris Meyer for Kaiser Health News) Medicare’s annual open-enrollment season is here and millions of beneficiaries — prompted by
Read More(By Jon Hamilton for NPR) The new Alzheimer’s drug Aduhelm isn’t reaching many patients. And doctors say reasons include its
Read More(By Matthew Herper for STAT) An experimental antiviral pill developed by Pfizer reduced the risk of death and hospitalization by
Read More(By Jaclyn Diaz for NPR) The chief law enforcement officials for Kentucky, Tennessee and Ohio are challenging the Biden administration’s mandate requiring federal
Read More